High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty: preliminary dosimetric tests of a new source presentation.

@article{Popowski1995HighDR,
  title={High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty: preliminary dosimetric tests of a new source presentation.},
  author={Youri Popowski and Vitali Dr Verin and Igor Isakovich Papirov and Philippe Nouet and Michel Rouzaud and E Grob and M Schwager and Philip Urban and Wilhelm Rutishauser and John M. Kurtz},
  journal={International journal of radiation oncology, biology, physics},
  year={1995},
  volume={33 1},
  pages={
          211-5
        }
}
PURPOSE Balloon dilatation of coronary artery stenosis has become a standard treatment of atherosclerotic heart disease. Restenosis due to excessive intimal cell proliferation, which subsequently occurs in 20-50% of patients, represents one of the major clinical problems in contemporary cardiology, and no satisfactory method for its prevention has thus far been found. Because modest doses of radiation have proved effective in preventing certain types of abnormal cellular proliferation resulting… CONTINUE READING